TP53 and cancer: In our previous work, we demonstrated that p53 activation is less robust in aneuploid mouse colon and human mammary organoids when compared with certain cancer and immortalized cell lines, pointing to the possible importance of tissue context or cell-type effects in the aneuploidy response (Narkar et al., 2021).